Larken Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LARKEN LABS INC, and what generic and branded alternatives to LARKEN LABS INC drugs are available?
LARKEN LABS INC has three approved drugs.
Summary for Larken Labs Inc
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Larken Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Larken Labs Inc | ALLZITAL | acetaminophen; butalbital | TABLET;ORAL | 203484-001 | Dec 4, 2015 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Larken Labs Inc | BUTALBITAL AND ACETAMINOPHEN | acetaminophen; butalbital | TABLET;ORAL | 203484-002 | Dec 4, 2015 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Larken Labs Inc | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 201270-001 | Jul 17, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Larken Labs Inc | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | acetaminophen; caffeine; dihydrocodeine bitartrate | TABLET;ORAL | 204209-001 | Sep 30, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
